Corcept Therapeutics (CORT) Net Margin Growth (1y) (2013 - 2026)

Corcept Therapeutics (CORT) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1,491.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -653.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Corcept Therapeutics 9.56 Bn 9.22 Bn 162.02 Mn -3,183.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,183.00
Dec 31, 2025 -488.00
Sep 30, 2025 -1,625.00
Jun 30, 2025 -364.00
Mar 31, 2025 -584.00
Dec 31, 2024 -629.00
Sep 30, 2024 36.00
Jun 30, 2024 -180.00
Mar 31, 2024 378.00
Dec 31, 2023 696.00
Sep 30, 2023 -874.00
Jun 30, 2023 -326.00
Mar 31, 2023 -937.00
Dec 31, 2022 -1,639.00
Sep 30, 2022 227.00
Jun 30, 2022 -246.00
Mar 31, 2022 -521.00
Dec 31, 2021 209.00
Sep 30, 2021 665.00
Jun 30, 2021 -303.00